Ondřej Topolčan
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 13
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 25
- Peptidase Inhibition and Analysis 16
- Lung Cancer Research Studies 15
-
- Lung Cancer Treatments and Mutations 21
- Prostate Cancer Treatment and Research 17
-
- Genetic factors in colorectal cancer 15
- Molecular Biology top 5%
-
- Neuroendocrine Tumor Research Advances 15
- Co-authors
- L HolubecVladislav TřeškaMartin PeštaRadek KučeraR. LamerzMichael J. DuffyCaj HaglundJindřich Fínek
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (3 papers)International Journal of Molecular Sciences (1 paper)
In The Last Decade
Ondřej Topolčan
240 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 148
- Cancer Research 1.1k
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.0k
- Pathology and Forensic Medicine 496
- Molecular Biology 1.3k
Countries citing papers authored by Ondřej Topolčan
This map shows the geographic impact of Ondřej Topolčan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ondřej Topolčan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ondřej Topolčan more than expected).
Fields of papers citing papers by Ondřej Topolčan
This network shows the impact of papers produced by Ondřej Topolčan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ondřej Topolčan. The network helps show where Ondřej Topolčan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ondřej Topolčan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 33 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 33 | |
| 9 | Využití softwarové fúze multiparametrické magnetické rezonance a transrektální ultrasonografie při cílené biopsii nejen signifikantního karcinomu prostaty | 2018 | 0 |
| 10 | 2017 | 27 | |
| 11 | 2017 | 15 | |
| 12 | [Biobanks European infrastructure]. | 2017 | 1 |
| 13 | 2017 | 3 | |
| 14 | Přínos stanovení [-2]proPSA v diferenciální diagnostice karcinomu prostaty | 2014 | 2 |
| 15 | 2014 | 1 | |
| 16 | 2014 | 28 | |
| 17 | Metabolický syndrom, predikce a prevence | 2012 | 0 |
| 18 | Nádorové markery karcinomu prostaty | 2008 | 1 |
| 19 | The importance of prognostic factors in premenopausal women with breast cancer. | 2007 | 21 |
| 20 | 2007 | 1 |
About Ondřej Topolčan
Ondřej Topolčan is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 254 papers that have together received 4.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (25 papers), Lung Cancer Treatments and Mutations (21 papers), Prostate Cancer Treatment and Research (17 papers), Peptidase Inhibition and Analysis (16 papers), Neuroendocrine Tumor Research Advances (15 papers), Genetic factors in colorectal cancer (15 papers), Lung Cancer Research Studies (15 papers) and Cancer, Lipids, and Metabolism (13 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.6k citations) and Pulmonary and Respiratory Medicine (1.0k citations). Ondřej Topolčan has collaborated with scholars based in Czechia, Germany and Finland. Frequent co-authors include L Holubec, Vladislav Třeška, Martin Pešta, Radek Kučera, R. Lamerz, Michael J. Duffy, Caj Haglund, Jindřich Fínek, Ladislav Pecen and Lars‐Erik Hansson. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.